The ADMYRIN brand, founded in 2013 (Switzerland), from 2951 sister brands and 17477 competing brands. The ADMYRIN brand is owned by NOVARTIS N, a company listed in Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. The sector of ADMYRIN is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(ADMYRIN)
over 5 years*
CHF 98.05